Does CARFILZOMIB Cause Encephalopathy? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Encephalopathy have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.3% of all adverse event reports for CARFILZOMIB.
59
Reports of Encephalopathy with CARFILZOMIB
0.3%
of all CARFILZOMIB reports
20
Deaths
38
Hospitalizations
How Dangerous Is Encephalopathy From CARFILZOMIB?
Of the 59 reports, 20 (33.9%) resulted in death, 38 (64.4%) required hospitalization, and 12 (20.3%) were considered life-threatening.
Is Encephalopathy Listed in the Official Label?
Yes, Encephalopathy is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Encephalopathy?
BACLOFEN (845)
METHOTREXATE (775)
ACETAMINOPHEN (608)
IFOSFAMIDE (585)
CYCLOPHOSPHAMIDE (552)
TACROLIMUS (523)
PREDNISONE (489)
DEXAMETHASONE (428)
METFORMIN (418)
ETOPOSIDE (404)
Which CARFILZOMIB Alternatives Have Lower Encephalopathy Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL